BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2026 9:40:36 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-01-23 09:59 |
|
Peer-Review Started |
|
2026-01-23 09:59 |
|
First Decision by Editorial Office Director |
|
2026-02-04 08:19 |
|
Return for Revision |
|
2026-02-04 08:19 |
|
Revised |
|
2026-02-12 06:18 |
|
Publication Fee Transferred |
|
2026-02-14 06:16 |
|
Second Decision by Editor |
|
2026-03-03 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-03 09:37 |
|
Articles in Press |
|
2026-03-03 09:37 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-26 00:43 |
|
Publish the Manuscript Online |
|
2026-07-13 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparative analysis of curative efficacy and prognostic factors across treatment modalities for early-stage hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen Zheng, Ping Lv, Qiang Zhu, Qing-Lin Zhang, Gang-Gang Yin and Wei-Gang Chen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Gang Chen, MD, Department of Gastroenterology, The First Affiliated Hospital of Shihezi University, No. 107, North 2nd Road, Hongshan Sub-district, Shihezi 832000, Xinjiang Uygur Autonomous Region, China., Shihezi 832000, China. 13579456959@126.com |
| Key Words |
Hepatocellular carcinoma; Overall survival rate; Progression free survival rate; Radiofrequency ablation; Curative resection |
| Core Tip |
Our findings support liver resection (LR) as the first-line preferred treatment modality for hepatocellular carcinoma (HCC) patients with Barcelona Clinic Liver Cancer 0/A stages. Simultaneously, we observed that combination therapy regimens achieve non-inferior overall survival and progression-free survival benefits compared to LR alone. Therefore, treatment-eligible early-stage HCC patients clinically indicated for combination therapy should actively pursue such regimens to attain similarly favorable prognostic outcomes. |
| Publish Date |
2026-07-13 09:40 |
| Citation |
Zheng W, Lv P, Zhu Q, Zhang QL, Yin GG, Chen WG. Comparative analysis of curative efficacy and prognostic factors across treatment modalities for early-stage hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(7): 119136
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i7/119136.htm |
| DOI |
https://doi.org/10.4251/wjgo.119136 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
